ES2003180A6 - Un metodo para preparar un polipeptido capaz de modular la actividad del crecimiento. - Google Patents

Un metodo para preparar un polipeptido capaz de modular la actividad del crecimiento.

Info

Publication number
ES2003180A6
ES2003180A6 ES8603468A ES8603468A ES2003180A6 ES 2003180 A6 ES2003180 A6 ES 2003180A6 ES 8603468 A ES8603468 A ES 8603468A ES 8603468 A ES8603468 A ES 8603468A ES 2003180 A6 ES2003180 A6 ES 2003180A6
Authority
ES
Spain
Prior art keywords
polypeptide
cells
proliferation
growth
modulating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8603468A
Other languages
English (en)
Spanish (es)
Inventor
Joyce M Zarling
Mohammed Shoyab
Hans Marquardt
Marcia B Hanson
Mario N Lioubin
Thomas Joseph Brown
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oncogen LP
Original Assignee
Oncogen LP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen LP filed Critical Oncogen LP
Publication of ES2003180A6 publication Critical patent/ES2003180A6/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
ES8603468A 1985-12-20 1986-12-17 Un metodo para preparar un polipeptido capaz de modular la actividad del crecimiento. Expired ES2003180A6 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81123585A 1985-12-20 1985-12-20
US93528386A 1986-11-26 1986-11-26

Publications (1)

Publication Number Publication Date
ES2003180A6 true ES2003180A6 (es) 1988-10-16

Family

ID=27123452

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8603468A Expired ES2003180A6 (es) 1985-12-20 1986-12-17 Un metodo para preparar un polipeptido capaz de modular la actividad del crecimiento.

Country Status (29)

Country Link
JP (1) JP2559035B2 (enrdf_load_stackoverflow)
KR (1) KR920005920B1 (enrdf_load_stackoverflow)
CN (1) CN1017626B (enrdf_load_stackoverflow)
AT (1) AT400444B (enrdf_load_stackoverflow)
AU (2) AU601168B2 (enrdf_load_stackoverflow)
BE (1) BE905957A (enrdf_load_stackoverflow)
CA (1) CA1340296C (enrdf_load_stackoverflow)
CH (1) CH675727A5 (enrdf_load_stackoverflow)
CY (1) CY1608A (enrdf_load_stackoverflow)
DE (2) DE3645095C2 (enrdf_load_stackoverflow)
DK (1) DK174094B1 (enrdf_load_stackoverflow)
ES (1) ES2003180A6 (enrdf_load_stackoverflow)
FI (1) FI91484C (enrdf_load_stackoverflow)
FR (1) FR2597108B1 (enrdf_load_stackoverflow)
GB (1) GB2185485B (enrdf_load_stackoverflow)
GR (1) GR862936B (enrdf_load_stackoverflow)
HK (1) HK65691A (enrdf_load_stackoverflow)
HU (1) HU210694B (enrdf_load_stackoverflow)
IE (1) IE59415B1 (enrdf_load_stackoverflow)
IL (1) IL81017A (enrdf_load_stackoverflow)
IT (1) IT1213428B (enrdf_load_stackoverflow)
LU (1) LU86718A1 (enrdf_load_stackoverflow)
NL (1) NL8603209A (enrdf_load_stackoverflow)
NO (1) NO174556C (enrdf_load_stackoverflow)
NZ (1) NZ218634A (enrdf_load_stackoverflow)
OA (1) OA08494A (enrdf_load_stackoverflow)
PT (1) PT83986B (enrdf_load_stackoverflow)
SE (1) SE505059C2 (enrdf_load_stackoverflow)
SG (1) SG60891G (enrdf_load_stackoverflow)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4645828A (en) * 1984-03-23 1987-02-24 Oncogen Platelet related growth regulator
NZ218634A (en) * 1985-12-20 1991-06-25 Oncogen Peptide identified by its cross reactivity with a cell growth factor, dna, antibodies to peptide and test kits
US5681930A (en) * 1985-12-20 1997-10-28 Bristol-Myers Squibb Company Anti-oncostatin M monoclonal antibodies
NZ226799A (en) * 1987-11-06 1991-08-27 Oncogen Breast cancer inhibitory factor and method for inhibiting proliferation of neoplastic cells and compositions therefor
ZA912137B (en) * 1990-03-29 1992-11-25 Oncogen Monocional antibodies that inhibit growth of kaposi's sarcoma
NO303226B1 (no) * 1990-03-29 1998-06-15 Bristol Myers Squibb Co Monoklonalt antistoff mot Onkostatin M, samt DNA-molekyl, cellelinje og hybridom
WO1992002556A1 (en) * 1990-08-02 1992-02-20 Michael Valentine Agrez Human colon cancer cell-derived fibroblast elongation factor
IL107040A0 (en) * 1992-09-25 1993-12-28 Lilly Co Eli Modified platelet factor-4

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132776A (en) * 1978-02-15 1979-01-02 University Patents, Inc. Delivery of immunologically active components of transfer factor
US4645828A (en) * 1984-03-23 1987-02-24 Oncogen Platelet related growth regulator
NZ218634A (en) * 1985-12-20 1991-06-25 Oncogen Peptide identified by its cross reactivity with a cell growth factor, dna, antibodies to peptide and test kits

Also Published As

Publication number Publication date
IT1213428B (it) 1989-12-20
JPS62236498A (ja) 1987-10-16
GB2185485B (en) 1990-07-04
HUT43103A (en) 1987-09-28
AU639048B2 (en) 1993-07-15
FI865156A0 (fi) 1986-12-17
LU86718A1 (fr) 1988-07-14
NO865178D0 (no) 1986-12-19
AT400444B (de) 1995-12-27
KR920005920B1 (ko) 1992-07-24
IL81017A0 (en) 1987-03-31
SE8605459D0 (sv) 1986-12-18
FI91484C (fi) 1994-07-11
FI865156L (fi) 1987-06-21
DE3643428A1 (de) 1987-09-24
HU210694B (en) 1995-06-28
CY1608A (en) 1992-04-03
SE8605459L (sv) 1987-06-21
AU6776590A (en) 1991-03-14
NZ218634A (en) 1991-06-25
NL8603209A (nl) 1987-07-16
HK65691A (en) 1991-08-23
IL81017A (en) 1993-01-14
IE59415B1 (en) 1994-02-23
PT83986B (pt) 1989-07-31
JP2559035B2 (ja) 1996-11-27
OA08494A (fr) 1988-07-29
DE3645095C2 (de) 1993-11-18
AU6660886A (en) 1987-06-25
GR862936B (en) 1987-10-28
DK615386D0 (da) 1986-12-18
PT83986A (en) 1987-01-01
FI91484B (fi) 1994-03-31
IT8622787A0 (it) 1986-12-19
AU601168B2 (en) 1990-09-06
NO174556B (no) 1994-02-14
DE3643428C2 (enrdf_load_stackoverflow) 1990-08-23
CA1340296C (en) 1998-12-29
SG60891G (en) 1991-08-23
GB2185485A (en) 1987-07-22
CN1017626B (zh) 1992-07-29
FR2597108A1 (fr) 1987-10-16
FR2597108B1 (fr) 1991-02-15
BE905957A (fr) 1987-06-17
CH675727A5 (enrdf_load_stackoverflow) 1990-10-31
NO174556C (no) 1994-05-25
GB8629997D0 (en) 1987-01-28
CN86108955A (zh) 1987-12-02
SE505059C2 (sv) 1997-06-16
IE863345L (en) 1987-06-20
DK174094B1 (da) 2002-06-10
DK615386A (da) 1987-06-21
NO865178L (no) 1987-06-22
ATA340686A (de) 1995-05-15
KR870005645A (ko) 1987-07-06

Similar Documents

Publication Publication Date Title
Murch et al. Direct evidence that inflammatory multinucleate giant cells form by fusion
AU560340B2 (en) Rennin from recombinant dna
Pryor Free radicals in biological systems
EP0796913A3 (en) GDP dissociation stimulating protein, brain-specific nucleosome assembly protein, skeletal muscle specific ubiquitin-conjugating enzyme, cell proliferation protein, phosphatidylinositolkinase, nel related proteins
FI854604A0 (fi) Onkostatiini-A:n käyttö diagnostisessa menetelmässä
ATE65798T1 (de) Menschlicher granuloxcyt-koloniestimulierungsfaktor.
ES8800343A1 (es) Un metodo para producir una proteina que contiene actividad biologica para coagulacion de sangre, mediada por factor viia
NL930127I1 (nl) Vorming van een meervoudig werkzame granulocytkolonie-stimulerende factor
DE3888642D1 (de) Rollflasche zur Züchtung von Zellengewebekulturen.
ATE400651T1 (de) Verwendung von grünem fluoreszenzprotein
ATE52502T1 (de) Verfahren zur herstellung tertiaerer aralkylurethane und verfahren zur herstellung von von ihnen abgeleiteten isocyanate.
AU6801487A (en) Method of producing a recombinant protein complex having human factor VIII:C activity
ES8504460A1 (es) Procedimiento para producir la totalidad o parte de las subunidades a y b de la toxina del colera
FI883082A0 (fi) Konstruering av syntetisk dna och dess anvaendning i syntes av stora polypeptider.
ES2003180A6 (es) Un metodo para preparar un polipeptido capaz de modular la actividad del crecimiento.
DE69225489D1 (de) Methode zur genetischen veränderung von knochenmarkzellen von primaten und dafür brauchbare zellen, die rekombinante retrovirale vektoren produzieren
PT86885A (pt) Metodo para inibir a proliferacao de uma pluralidade de celulas neoplasticas
ES2055686T3 (es) Procedimiento para preparar proteinas con factor de granulocitos-macrofagos "estimulador de colonias".
ES8504255A1 (es) Procedimiento para la produccion de una hormona de crecimiento de porcino.
ES2054612T3 (es) Secuencias de adn que codifican para proteinas con actividad biologica de los inhibidores husi tipo-i y procedimientos tecnologicos geneticos para la preparacion de estas proteinas.
ATE348876T1 (de) Verfahren zur vermehrung von natürlichen killerzellen
DE3583634D1 (de) Gentechnologisches verfahren zur herstellung von human-interleukin-2 und mittel zur durchfuehrung dieses verfahrens.
AUPN896596A0 (en) Therapeutic molecules
ATE211390T1 (de) Überlegende thrombomodulinanaloga zur pharmazeutischen verwendung
ES8302089A1 (es) Procedimiento para la preparacion microbiologica de un polipeplido que contiene total o parcialmente la secuencia de aminoacidos del interferon de fibrobastos humanos.

Legal Events

Date Code Title Description
SA6 Expiration date (snapshot 920101)

Free format text: 2006-12-17

FD1A Patent lapsed

Effective date: 20061218